Contact Us
Continuing Medical Education
- cme@lsuhsc.edu
- 504-568-2000
- 504-599-1453
- 2020 Gravier Street, Suite 602
New Orleans, LA 70112
Tumor Board
University Medical Center
Target Audience:
The primary target audience for this CME activity is faculty, residents, students, invited guests and other healthcare professionals practicing in the LSU Health System, LSU affiliated hospitals and communities within the State of Louisiana for whom this is within the current or potential scope of professional activities. The purpose of this activity is to promote improvements in healthcare in Louisiana.
activity Learning Objectives:
At the conclusion of this activity, the learner should be better able to:
- Develop comprehensive, evidence-based surgical management plans for patients with
solid organ and soft tissue malignancies through multidisciplinary collaboration.
-
Interpret and integrate radiologic, pathologic, and molecular diagnostic data to support accurate oncologic staging and guide surgical decision-making.
-
Apply current clinical guidelines and emerging research findings to inform the timing, approach, and extent of surgical intervention in cancer care.
-
Evaluate surgical candidacy and operative risk by considering tumor biology, patient comorbidities, and response to neoadjuvant therapies.
- Enhance interdisciplinary communication and coordination with oncology, radiology, pathology, and other specialties to improve perioperative and longitudinal outcomes in cancer patients.
When / Where:
Weekly Tuesdays 7:00-8:00 AM (hybrid)
Activity Medical Director:
Omeed Moaven, MD
ACTIVITY COORDINATOR:
To subscribe to the activity listserv, please click here: subscribe
Accreditation:
The Louisiana State University School of Medicine, New Orleans is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Louisiana State University School of Medicine, New Orleans designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA Credit Designation Statement:
The Louisiana State University School of Medicine, New Orleans designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure:
The Louisiana State University School of Medicine, New Orleans (LSUSOMNO) ensures balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Faculty, planners or anyone in a position to control content are required to disclose to participants any financial relationships they may have had with ineligible entities within the last 24 months, including in-kind donations. An ineligible entity is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. Disclosure of financial relationships must be made during the planning stages of the activity, and all relationships thus disclosed are communicated to the audience prior to the activity.
Obtaining your CME credit for attending this conference
All attendees are expected to use one of the approved methods to check-in or log-in to the conference. Attendance is tracked, uploaded and available on the CME transcript for LSUHSC.edu eligible learners. Additionally, credit is transmitted to the LSBME's CE Broker system monthly for those Louisiana LICENSED physicians (those working on permits are not allowed to be transmitted).
University Medical Center Tumor Board 2025
UMC Tumor Board 4/15/2025
Drs. Bradley and Chou
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 4/22/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 4/29/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 5/13/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 5/20/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 5/27/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 6/3/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 6/10/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 6/17/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 6/24/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 7/1/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 7/8/2025
1.00 AMA PRA Category 1 Credits™
UMC Tumor Board 7/15/2025
1.00 AMA PRA Category 1 Credits™